Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial

Double Blind ◽

Effects of vitamin D on serum levels and gene expression of enzymes aldose reductase, o-linked n-acetyl glucosamine transferase and glutamine fructose-6-phosphate aminotransferase in patients with type 2 diabetes: a randomized, double blind, placebo controlled clinical trial

International Journal of Food Properties ◽

10.1080/10942912.2021.1879131 ◽

2021 ◽

Vol 24 (1) ◽

pp. 337-345

Author(s):

Mahnaz Zarei ◽

Mohammad Hassan Javanbakht ◽

Hanieh Jafary ◽

Mahmoud Djalali

Keyword(s):

Gene Expression ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Vitamin D ◽

Aldose Reductase ◽

Serum Levels ◽

Double Blind ◽

A double‐blind placebo‐controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design

Alzheimer s & Dementia Translational Research & Clinical Interventions ◽

10.1002/trc2.12008 ◽

2020 ◽

Vol 6 (1) ◽

Author(s):

Ori BenAri ◽

Shai Efrati ◽

Amir Hadanny ◽

Mary Sano ◽

Barbara B. Bendlin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Oxygen Therapy ◽

Cognitive Outcomes ◽

Cognitively Impaired ◽

Double Blind ◽

Double Blind Placebo ◽

Trial Testing

The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial

Acta Diabetologica ◽

10.1007/s00592-017-1098-3 ◽

2018 ◽

Vol 55 (4) ◽

pp. 341-353 ◽

Cited By ~ 44

Author(s):

ShadiSadat Seyyedebrahimi ◽

Hadi Khodabandehloo ◽

Ensieh Nasli Esfahani ◽

Reza Meshkani

Keyword(s):

Oxidative Stress ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Markers Of Oxidative Stress

Effect of Tocotrienols enriched canola oil on glycemic control and oxidative status in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial

Journal of Research in Medical Sciences ◽

10.4103/1735-1995.165945 ◽

2015 ◽

Vol 20 (6) ◽

pp. 540 ◽

Cited By ~ 12

Author(s):

Mohammadreza Vafa ◽

Nazanin Moslehi ◽

Iraj Heydari ◽

Neda Haghighat ◽

Shahriar Eghtesadi

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Type 2 Diabetes Mellitus ◽

Canola Oil ◽

Oxidative Status ◽

Double Blind ◽

Hesperidin Supplementation Alleviates Oxidative DNA Damage and Lipid Peroxidation in Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Clinical Trial

Phytotherapy Research ◽

10.1002/ptr.5881 ◽

2017 ◽

Vol 31 (10) ◽

pp. 1539-1545 ◽

Cited By ~ 25

Author(s):

Fatemeh Homayouni ◽

Fatemeh Haidari ◽

Mehdi Hedayati ◽

Mehrnoosh Zakerkish ◽

Kambiz Ahmadi

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Lipid Peroxidation ◽

Dna Damage ◽

Oxidative Dna Damage ◽

Double Blind ◽

Effects of Supplementation with Main Coffee Components on Hepatic, Metabolic, and Inflammatory Indices in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3397199 ◽

2019 ◽

Cited By ~ 1

Author(s):

Asieh Mansour ◽

Mohammad Reza Mohajeri-Tehrani ◽

Majid Samadi ◽

Mostafa Qorbani ◽

Shahin Merat ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Liver Disease ◽

Fatty Liver Disease ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

21-OR: Final Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the MetAP2 Inhibitor ZGN-1061 in Patients with Type 2 Diabetes

Diabetes ◽

10.2337/db19-21-or ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 21-OR ◽

Cited By ~ 2

Author(s):

TERRI KIM ◽

DONGLIANG ZHUANG ◽

TONYA L. HAUGEN ◽

DENNIS D. KIM ◽

KRISTIN TAYLOR

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Phase 2 ◽

Double Blind ◽

Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial

BMC Complementary and Alternative Medicine ◽

10.1186/1472-6882-14-237 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 34

Author(s):

Mi-Ra Oh ◽

Soo-Hyun Park ◽

Sun-Young Kim ◽

Hyang-Im Back ◽

Min-Gul Kim ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Fasting Glucose ◽

Postprandial Glucose ◽

Red Ginseng ◽

Double Blind ◽

Glucose Lowering ◽

Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPARγ Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Journal of Nutrigenetics and Nutrigenomics ◽

10.1159/000442792 ◽

2015 ◽

Vol 8 (4-6) ◽

pp. 195-204 ◽

Cited By ~ 7

Author(s):

Anahita Mansoori ◽

Gity Sotoudeh ◽

Mahmoud Djalali ◽

Mohammad-Reza Eshraghian ◽

Mohammad Keramatipour ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Body Composition ◽

Docosahexaenoic Acid ◽

Pro12ala Polymorphism ◽

Double Blind ◽

Double Blind Placebo ◽

Fish Oil Supplementation

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk

Cardiovascular Diabetology ◽

10.1186/s12933-018-0682-3 ◽

2018 ◽

Vol 17 (1) ◽

Cited By ~ 49

Author(s):

Julio Rosenstock ◽

◽

Vlado Perkovic ◽

John H. Alexander ◽

Mark E. Cooper ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Outcome Study ◽

Cardiovascular Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Baseline Characteristics